Dopamine-agonist combination therapy for improving sleep quality

Details for Australian Patent Application No. 2011201703 (hide)

Owner Sunovion Pharmaceuticals Inc.

Inventors Barberich, Timothy J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011201703

Parent 2005215376

Filing date 15 April 2011

Wipo publication date 12 May 2011

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 April 2011 Complete Application Filed

12 May 2011 Application Open to Public Inspection

  Published as AU-A-2011201703

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201704-Live conductor stringing and splicing method and apparatus

2011201702-Coin hopper